Overview

Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Introduction: remifentanil's optimal dose for children intubation without neuromuscular blockade is unknown. Method: phase IV adaptative trial using Dixon's up-and-down method for modeling remifentanil's dose-response curve for adequate intubation conditions as defined by previous studies.
Phase:
Phase 4
Details
Lead Sponsor:
Brasilia University Hospital
Collaborator:
University of Brasilia
Treatments:
Remifentanil